Replies

These guys? I never heard what they had to say before you mentioned them

Here is an extract

Tobacco researchers talk about the gap between what we know and what we do. What we know is that most smokers want to quit, most see a doctor at least once a year, and most doctors want to help them quit. Moreover, we know that the nation could double its current national annual rate of quitting if doctors routinely offered brief advice, counseling, and effective pharmacotherapy (such as the nicotine patch or Zyban) that the Guideline recommends. Unfortunately, only 50–60 percent of smokers report getting any advice on quitting from their physicians, and fewer than 25 percent report any further counseling or drug-based therapy. Low-income and minority smokers are the least likely to get this help.

Granted, the gap between what we know and what we do has grown smaller. The number of quitters who currently make use of effective treatments is somewhere between 20 and 30 percent, which is twice as high as it was a decade ago.⁶ There are plenty of reasons to explain why this gap has not shrunk further:

Doctors and other primary care practitioners are not trained
to deliver tobacco-cessation therapies. For example, fewer than
20 percent of medical schools offer even three hours of clinical instruction in treating tobacco addiction.⁷
Physicians underestimate the difficulty smokers face in overcoming tobacco addiction and feel discouraged by what they perceive as their own lack of success in helping them. Even those who qualify (by helping their patients quit) for what Fiore calls “the good doctor club” note that if they succeed in getting one in five of their smoking patients to stop—a major public health achievement—results are typically delayed and invisible.
The health care system does not support tobacco-cessation efforts. Surveys funded by The Robert Wood Johnson Foundation show that physicians who work to put the clinical practice Guideline into action do so without reminder and follow-up systems, without access to self-help materials, telephone quit lines, or community programs required to deliver effective counseling outside the eighteen-minute clinical visit.
Insurance coverage and reimbursement policies often do not cover tobacco-dependence treatment that is known to be effective. Medicare, for example, still provides no coverage, and in 2000 only thirty-three states provided Medicaid coverage for any of the proven treatments recommended by the Guideline.
The business case for tobacco-dependence treatment has not been made. Most purchasers of health care (such as large corporations), most policy makers, and most benefit consultants are not aware of the actual costs of illness related to smoking or of the economic benefits of quitting.⁸ Businesses are unenthusiastic about anything but an immediate return on investment. “Health plans are fighting for their financial lives right now, and many of them claim that since member turnover is so high, they won’t realize the savings three or four years down the road for money they’re spending today,” says Barbara Lardy, director of medical affairs for the American Association of Health Plans, managed care’s national trade organization.
The community treating tobacco dependence does not think along policy lines. During a time when prevention policies were driving down the number of young people who took up smoking, few advocates focused on the power of these policies to induce smokers to quit. Similarly, until recently, policy makers and policy researchers largely ignored policy and regulatory strategies for tobacco cessation.
Even though most smokers want to quit and try to do so, this desire has not translated into demand for treatment. In a focus group funded by The Robert Wood Johnson Foundation, officials from health plans offering the most generous smoking-cessation treatments and benefits voiced a common frustration over smokers’ generally low use of these services.⁹ Not that there has been much done to build demand. Aside from recent direct-to-consumer advertising for nicotine gum and patches and Zyban, there have been few efforts to educate smokers about effective treatment. Aids and programs to reduce tobacco dependence are far less available to smokers than are cigarettes.
http://www.rwjf.org/files/publications/books/2003/chapter_06.html